Identification of the Novel HLA ‐A*32:202 Allele by Next‐Generation Sequencing and Oxford Nanopore Sequencing
HLA · 2026-04 · 107 (4)
DOI: 10.1111/tan.70687 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 24.03.2026. Verfasst von Ruby J Siegel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Alleles, Exons, HLA-A Antigens, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
HLA‐A*32:202 differs from HLA‐A*32:01:01:01 by two nucleotide substitutions in exons 1 and 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona, USA.
- Gift of Hope Organ & Tissue Donor Network, Itasca, Illinois, USA.
ORCID-Profile: Ruby J Siegel, Sam Ho, Katrin Hacke, Andrés Jaramillo
Zitieren
APA
Siegel, R. J., Ho, S., Hacke, K., Ridgley, R. M., & Jaramillo, A. (2026). Identification of the Novel HLA ‐A*32:202 Allele by Next‐Generation Sequencing and Oxford Nanopore Sequencing. HLA, 107(4). https://doi.org/10.1111/tan.70687
Vancouver
Siegel RJ, Ho S, Hacke K, Ridgley RM, Jaramillo A. Identification of the Novel HLA ‐A*32:202 Allele by Next‐Generation Sequencing and Oxford Nanopore Sequencing. HLA. 2026;107(4). doi:10.1111/tan.70687
BibTeX
@article{Siegel2026,
author = {Siegel, Ruby J and Ho, Sam and Hacke, Katrin and Ridgley, Rose M and Jaramillo, Andrés},
title = {Identification of the Novel HLA ‐A*32:202 Allele by Next‐Generation Sequencing and Oxford Nanopore Sequencing},
journal = {HLA},
year = {2026},
volume = {107},
number = {4},
doi = {10.1111/tan.70687}
}
EUVIMED